USP21 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.623600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.568800E-01
Normal-vs-Stage2
3.697400E-01
Normal-vs-Stage3
5.365900E-02
Normal-vs-Stage4
9.792200E-01
Stage1-vs-Stage2
7.327400E-01
Stage1-vs-Stage3
4.705900E-02
Stage1-vs-Stage4
6.280400E-01
Stage2-vs-Stage3
2.518400E-02
Stage2-vs-Stage4
3.317400E-01
Stage3-vs-Stage4
9.137500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.143000E-01
Normal-vs-AfricanAmerican
6.488800E-01
Normal-vs-Asian
9.970800E-01
Caucasian-vs-AfricanAmerican
4.605400E-01
Caucasian-vs-Asian
7.001700E-02
AfricanAmerican-vs-Asian
6.599600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.216800E-01
Normal-vs-Female
3.088800E-01
Male-vs-Female
3.594200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.082200E-01
Normal-vs-Age(41-60Yrs)
3.343600E-01
Normal-vs-Age(61-80Yrs)
3.823800E-01
Normal-vs-Age(81-100Yrs)
4.732600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.715400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.551800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.367800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.860000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.467200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.120000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.984640E-01
Normal-vs-Daily Drinker
1.835190E-01
Normal-vs-Weekly Drinker
3.738600E-01
Normal-vs-Occasional Drinker
9.844400E-01
Normal-vs-Social Drinker
3.533400E-01
Non Drinker-vs-Daily Drinker
9.113400E-01
Non Drinker-vs-Weekly Drinker
5.765400E-01
Non Drinker-vs-Occasional Drinker
8.018800E-03
Non Drinker-vs-Social Drinker
3.327200E-01
Daily Drinker-vs-Weekly Drinker
5.329600E-01
Daily Drinker-vs-Occasional Drinker
8.217800E-03
Daily Drinker-vs-Social Drinker
2.982200E-01
Weekly Drinker-vs-Occasional Drinker
8.431900E-02
Weekly Drinker-vs-Social Drinker
7.618000E-01
Occasional Drinker-vs-Social Drinker
9.947500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.620200E-02
Normal-vs-Grade 2
5.278400E-03
Normal-vs-Grade 3
4.744100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.295600E-01
Grade 1-vs-Grade 3
5.808800E-01
Grade 1-vs-Grade 4
3.620200E-02
Grade 2-vs-Grade 3
9.843400E-01
Grade 2-vs-Grade 4
5.278400E-03
Grade 3-vs-Grade 4
4.744100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.171400E-01
Normal-vs-NonDiabetic
4.235800E-01
Diabetic-vs-NonDiabetic
8.777900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.399000E-01
Normal-vs-NoPancreatitis
3.396200E-01
Pancreatitis-vs-NoPancreatitis
6.669400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.172200E-01
Normal-vs-N1
3.087200E-01
N0-vs-N1
1.927650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.628200E-01
Normal-vs-TP53-NonMutant
7.896400E-01
TP53-Mutant-vs-TP53-NonMutant
9.998200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
